Treatment of iron deficiency anemia with erythropoies-enhancing drugs - Bektasheva, Gulbahor; Abdulazizxojiyev, Boburbek
32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
16 °P sammeln
  • Broschiertes Buch

According to the World Health Organization, about 4 billion people worldwide suffer from iron deficiency, with at least half experiencing iron deficiency anemia (IDA). IDA leads to stress, reduced productivity in adults, and stunted growth in children. It is linked to quality of life, societal development, and environmental factors. Iron deficiency occurs when the body absorbs less iron than required or loses more. Iron is essential for oxygen transport, mitochondrial function, antioxidant protection, hematopoiesis, and DNA synthesis. Daily iron needs vary by gender, age, and geography. For…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
According to the World Health Organization, about 4 billion people worldwide suffer from iron deficiency, with at least half experiencing iron deficiency anemia (IDA). IDA leads to stress, reduced productivity in adults, and stunted growth in children. It is linked to quality of life, societal development, and environmental factors. Iron deficiency occurs when the body absorbs less iron than required or loses more. Iron is essential for oxygen transport, mitochondrial function, antioxidant protection, hematopoiesis, and DNA synthesis. Daily iron needs vary by gender, age, and geography. For example, women of reproductive age need around 2 mg, while older men need 1 mg. Maintaining the right balance of iron is crucial for women with regular menstruation. This study explores the risks and symptoms of iron deficiency, its diagnosis, and the appropriate therapy.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Gulbakhar Bektasheva is a fifth-year medical student of ASMI. She has participated in numerous international olympiads and conferences, where she has emerged as a winner.